The changes of gene expression in multiple myeloma treated with thalidomide].

To investigate the effect of thalidomide on bone marrow cells gene expression in multiple myeloma (MM) patients with suppression subtractive hybridization (SSH) and explore the molecular mechanism of thalidomide therapy for MM. In a MM patient receiving thalidomide therapy and bone marrow cell from himself, total RNA extraction, mRNA isolation and cDNA synthesis were carried out respectively with routine procedures. SSH were performed in A and B group respectively. The subtracted cDNA was selectively amplified by suppression PCR. The product was inserted into T vector, and then transfected into the competent host JM109. So two subtractive libraries were constructed. After blue-white screening, colonies were selected and plasmids extracted. Homologous comparation was conducted in GenBank. In group A, seven clones were isolated, including ribosomal protein L19 (HUMAN), IgG lambda chain v-v region (HUMAN), contains Alu repetitive element, NADH-ubiquinone oxidoreductase chain 2, elongation factor 1-gamma, human beta globin region, and 40S ribosomal protein S4 (HUMAN). In group B, six clones were isolated, including cytochrome B, up-regulated by 1,25-dihydroxyvitamin D(3) (VDUP1), NADH- ubiquinone oxidoreductase 20 Kd subunit, mu-calpain large subunit, tumor protein, translationally-controlled 1 (TPT1) and COATOMER alpha subunit. Thalidomide induces apoptosis and antiangiogenesis by down-regulating some genes and up-regulating some others genes.

Citation

Hai-bo Zhang, Shi-lun Chen, Jing-zhong Liu, Bai Xiao, Zhen-bin Chen, Hui-juan Wang. The changes of gene expression in multiple myeloma treated with thalidomide]. Zhonghua nei ke za zhi [Chinese journal of internal medicine]. 2003 May;42(5):300-2

Mesh Tags

Substances

PMID: 12882707

search → result